Botanical Formula Slows Breast Cancer Metastasis

In a recent study it was found that Modified Citrus Pectin (MCP) can boost the anti-cancer effects of two poly-botanical formula.

It was found that when co-administered with formulas that attack breast and prostate cancer, MCP significantly increased their anti-cancer action, further cutting down the metastasis in highly invasive breast and prostate cancer cells.

Screening for Breast Cancer with Clinical Breast Examination
Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.

The study was led by researchers at the Cancer Research Laboratory at Indiana University Health and Indiana University School of Medicine.

"We asked a simple question of whether one plus one can equal more than two," said lead investigator Dr. Daniel Sliva, associate professor at the Indiana University School of Medicine.

"We know that certain molecules in cancer cells are responsible for their aggressive behavior. The synergistic effects seen in this study show that we can further suppress these molecules and significantly reduce the cancer cells' aggressiveness," said Sliva.

Prostate Cancer
Interactive section of Medindia gives details regarding Prostate Cancer

In the study, low concentrations of the anti-breast cancer formula reduced breast cancer cell adhesion to human fibronectin by 21 percent.

However, when co-administered with Modified Citrus Pectin, researchers observed a 40 percent decrease in the malignant cells.

Cardio-Pulmonary Function can be a Strong Indicator for Survival Chances of Breast Cancer Patients
A new study has revealed that women who are treated for breast cancer can have significantly impaired cardio-pulmonary function.

In addition, the anti-prostate cancer formula, when administered alone, reduced prostate cancer cell adhesion by 9 percent.

And when MCP was added, adhesion was suppressed by up to 40 percent.

Heat Shock Protein Inhibitor And Hormonal Therapy Combo Tested in Breast Cancer Clinical Trial
Pushed to the brink of survival, the hyper-driven cells of a cancerous tumor tap into an ancient system that has helped organisms cope with internal

The study also showed that cancer cell migration was also decreased by combining MCP with the prostate and breast formulas.

"This new study is particularly important because it demonstrates that when MCP is combined with either the prostate or breast formula, lower dosages provided more powerful synergistic anti-cancer effects than were observed when these supplements were studied on their own," added Dr. Isaac Eliaz, co-author and formulator.

This study has been published in the peer review journal Integrative Cancer Therapies.

Source-ANI